Aviado · Research
Longevity Daily
Wednesday, April 29, 2026
Listen
Today's Brief
Today's biggest story asks a question every rapamycin user needs to face: does the drug's mTOR-blocking mechanism interfere with exercise gains? The Washington Post breaks down emerging evidence that's more nuanced than a simple "don't train on drug days." Also this issue: a landmark AHA statement reframes brain health as a lifelong, modifiable target, and the first human trial confirms the fasting-mimicking diet triggers real autophagy. And Congress moved this week on FDA reform bills that could reshape how supplements are regulated for years to come.
10 stories3 peer-reviewed1 trials
Cognitive Health & Neuroprotection
AHA Reframes Brain Health as Lifelong and Modifiable in Landmark Scientific Statement
The American Heart Association has issued a major scientific statement establishing that brain health is shaped not just by genetics, but by a lifetime of mental, physical, social, and environmental factors — all of which are modifiable. The statement specifically highlights sleep quality, mental health conditions, environmental exposures, and social connection as underappreciated levers, and notes that following the AHA's Life's Essential 8 metrics supports measurable brain-health outcomes. If your cardiovascular health profile is strong, your brain is likely along for the ride — and vice versa.
Read more →Nearly Half of Seniors' Antipsychotic Prescriptions Start in Hospitals — and Most Never Stop
A new analysis finds that 43% of antipsychotic prescriptions in older adults originate during hospital stays — and that these prescriptions are 'sticky,' often continuing for over a year after discharge without reassessment. Antipsychotics carry FDA black-box warnings about increased mortality in elderly dementia patients, yet are routinely used off-label to manage behavioral symptoms. If an older family member is hospitalized, this is a critical reminder to ask directly about any new psychiatric medications being started — and to push for a clear discontinuation plan before discharge.
Read more →Supplements & Compounds
First Human Trial Confirms Fasting-Mimicking Diet Triggers Autophagy
After decades of animal data, a human clinical trial has directly confirmed that the ProLon fasting-mimicking diet activates autophagy — the cellular 'self-cleaning' process that ranks among the most sought-after targets in longevity science. The trial, registered in GeroScience, showed measurable autophagy induction in participants completing the 5-day FMD protocol. Important caveat: the study was funded by L-Nutra, the maker of ProLon, so independent replication is needed — but for those already running periodic fasting cycles, this is meaningful first-in-human proof-of-concept.
Read more →19 Controversial Peptides Ranked by Evidence: What the Longevity Community Is Actually Taking
Men's Health breaks down 19 of the most-discussed peptides in longevity and biohacking circles — including the popular CJC-1295 and Ipamorelin stack, used for growth hormone support, sleep improvement, and muscle preservation. The piece doesn't shy away from evidence gaps: some compounds show clinical promise for specific uses, but others carry meaningful adverse event profiles or lack any human safety data entirely. Before experimenting, treat this as a field guide — risk-benefit profiles vary dramatically across the list.
Read more →Research & Papers
Rapamycin May Blunt Exercise Gains — Here's What Longevity Users Need to Know
The Washington Post investigates a growing concern for longevity enthusiasts taking low-dose rapamycin off-label: by blocking mTOR — the same molecular pathway that drives muscle adaptation after exercise — the drug may interfere with the fitness gains your workouts are meant to produce. Animal studies and early human data suggest that timing and dosing of rapamycin relative to exercise sessions could matter enormously. The story surveys what researchers currently know and don't know about stacking a lifespan-extending drug with a training protocol. If you're taking rapamycin, this is essential context before deciding whether to adjust your schedule.
Read more →AI Reads Biological Aging Rate from Serial Facial Photos — and It Predicts Survival
Researchers applied an AI algorithm called FaceAge to serial clinical photographs of 2,276 cancer patients to calculate each person's Face Aging Rate (FAR) — essentially, how quickly their biological age was advancing between photos. Higher FAR was strongly associated with worse survival outcomes, with hazard ratios reaching 1.65 for patients photographed more than two years apart after adjusting for sex, race, and diagnosis. Current validation is in oncology settings only, but this non-invasive biomarker points toward a future where routine photographs could serve as a meaningful biological aging clock.
Read more →HIV Drug Maraviroc Reverses Muscle Aging by Silencing 'Zombie Cell' Signals
Researchers at The Chinese University of Hong Kong built the first comprehensive atlas of senescent cells in human skeletal muscle, then identified a specific inflammatory signal driving sarcopenia — and found that Maraviroc, an already-approved HIV antiretroviral, could block it. Unlike traditional senolytics that destroy senescent cells outright, this approach targets the harmful secretions (SASP) those cells emit in aging muscle tissue. This is preclinical work, but the use of an existing approved drug with a clearly mapped mechanism makes it one of the more translatable sarcopenia stories in recent months.
Read more →Lifestyle & Nutrition
Exercise Activates SIRT1 — Your Body's Most Versatile Anti-Aging Enzyme
A new review in Biogerontology makes the case that SIRT1 functions as a key 'exerkine' — a molecule activated by exercise that directly counters multiple hallmarks of aging across the hippocampus, heart, liver, and skeletal muscle. Both aerobic and resistance training increase SIRT1 activity in aged animals and older humans, improving mitochondrial dynamics, autophagy, inflammatory control, and genomic integrity. The practical takeaway: consistent, varied training isn't just cardiovascular medicine — every session is also an SIRT1-activating longevity intervention.
Read more →Industry & Policy
Congress Opens Hearing on FDA Reform Bills That Could Reshape Supplement Regulation
The U.S. House Energy and Commerce Subcommittee on Health held a legislative hearing on April 29 on a broad set of bills targeting how the FDA regulates dietary supplements, food ingredients, and related products. The push — accelerating under the current administration's deregulatory agenda — could affect ingredient approval pathways, labeling requirements, and safety oversight in ways that directly impact what's on supplement shelves and how it's vetted. Holland & Knight's breakdown is essential reading for anyone with a stake in the supplement market.
Read more →FDA Draws Clearer Line Between Dietary Supplements and Functional Beverages
The FDA has issued final draft guidance clarifying when a liquid product marketed as a dietary supplement legally crosses into conventional beverage territory — carrying misbranding implications for manufacturers. Under the guidance, packaging format, serving size, and marketing language can collectively reclassify a supplement as a food product subject to entirely different regulatory rules. Consumers buying liquid supplements or functional drinks should expect labeling changes as manufacturers adjust to comply.
Read more →